Institute for Liver Health

Early Remdesivir to Prevent Progression to Severe Covid-19 in Outpatients

Robert Gottlieb, Carlos Vaca, Roger Paredes et al. · New England Journal of Medicine · 2021 · 1.3K citations · Full text

Pharmacy, Internal Medicine, Pharmacotherapy +13

Selonsertib for patients with bridging fibrosis or compensated cirrhosis due to NASH: Results from randomized phase III STELLAR trials

Stephen A. Harrison, Vincent Wai‐Sun Wong, Takeshi Okanoue et al. · Journal of Hepatology · 2020 · 466 citations

Medicine, Internal Medicine, Pharmacotherapy +12

Therapeutic Clearance of Amyloid by Antibodies to Serum Amyloid P Component

Duncan Richards, Louise Cookson, Aliénor Berges et al. · New England Journal of Medicine · 2015 · 376 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +15

A Randomized Trial of Albumin Infusions in Hospitalized Patients with Cirrhosis

Louise China, Nick Freemantle, Ewan Forrest et al. · New England Journal of Medicine · 2021 · 321 citations · Full text

Medicine, Internal Medicine, Pharmacotherapy +17

Noninvasive Tests Accurately Identify Advanced Fibrosis due to NASH: Baseline Data From the STELLAR Trials

Quentin M. Anstee, Eric Lawitz, Naim Alkhouri et al. · Hepatology · 2019 · 266 citations

Medicine, Internal Medicine, Pathology +17